Pharma Data Routing Without Centralization: Why the Research Triangle Needs QIS
This article discusses a new protocol called Quadratic Intelligence Swarm (QIS) that enables distributed data synthesis and pharmacovigilance signal detection across multiple clinical trial sites without centralized data storage.
Why it matters
QIS enables distributed data synthesis and faster safety signal detection in the pharma industry, without the need for centralized data storage.
Key Points
- 1QIS allows multi-site clinical trial data to be synthesized without a central data lake
- 2QIS enables faster pharmacovigilance signal detection across distributed sites
- 3QIS routes validated outcome data packets between sites using semantic addressing, without exposing raw patient data
Details
The Research Triangle Park region in North Carolina is home to a dense biomedical research ecosystem, but organizations operating here face a common challenge - they generate massive volumes of clinical data across distributed sites, which they cannot centralize due to regulatory requirements. The current model of aggregating summary statistics at a central database limits the opportunities for direct synthesis between sites. QIS solves this by allowing sites to distill their validated outcomes into compact data packets, which are then routed between sites with similar patient populations using semantic addressing. This enables 11,175 pairwise synthesis opportunities instead of just 150 linear contributions. For pharmacovigilance, QIS allows rapid detection of safety signals that may be invisible to individual sites, by continuously monitoring the semantic address space for correlated events across sites, without any raw patient data being shared.
No comments yet
Be the first to comment